Home Tags Lonza

Tag: Lonza

Seattle Genetics

5 Things You Need To Know This Week About ADCs –...

This is the second article in my series of updates about the goings on in the world of ADCs over the last two weeks....

Lonza’s Collaborative Innovation Center Helps Rethink Development and Manufacturing

A new Collaborative Innovation Center in the Haifa Life Science Park, Haifa, Israel, developed and managed by Lonza Pharma & Biotech, will acts as...
Featured Image: Lonza, Visp, Switzerland. Courtesy: © 2010 - 2018 Lonza, Visp, Switzerland. Used with permission.

Lonza Expands Manufacturing Capacity for ADC Payloads

Lonza, a specialty contract development and manufacturing (CDMO) partner to the biopharma industry, will add new highly potent API (HPAPI) manufacturing suites at its...

Lonza acquires U.S. Manufacturing Site from Shire

Lonza is acquiring a clinical-stage mammalian manufacturing site in the United States from Dublin-based Shire.The 58,000-square-foot (approximately 5,388-square-meter) site, located in Hayward, in...

Lonza – Celebrating 10 Years as ADC Manufacturing Pioneer

By leveraging the company's experience in biopharmaceuticals and small molecule drug process development and scale-up, Lonza has been successful in manufacturing antibody-drug conjugates, a...

New Lonza Facility Focuses on Formulation Development, Drug Product Analytical Development...

Earlier this year, Lonza, a global leader in chemical and biological manufacturing, held the grand opening of its new state-of-the-art pharmaceutical Drug Product Services...

Lonza Expands it’s Mammalian Production Capacity

Over the last decade, biologics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), therapeutic proteins, immunotherapeutics, and therapeutic (cancer) vaccines have greatly transformed treatment of...

Q&A – an Interview with Lonza’s Laurent Ducry

Antibody-drug Conjugates or ADCs are among the most exciting drug developments of the last decade. The combination of potent, small molecule drugs with the...

Event Preview: CPhI Worldwide 2015

CPhI Worldwide 2015 returns to Madrid, Spain, for the 26th edition, bringing with it the booming pharmaceutical industry ready for a plethora of networking,...

Sorrento Therapeutics Completes Acquisition of Concortis Biosystems

Sorrento Therapeutics, Inc. announced today that it has completed its acquisition of Concortis Biosystems, Corp. The transaction provides Sorrento with a comprehensive antibody-drug conjugate...